A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
TCL1, IHC without Interpretation
Test Code90402
CPT Codes
88342
Preferred Specimen
Formalin-fixed, paraffin-embedded block collected in an IHC Specimen Transport Kit
Minimum Volume
3 slides
Other Acceptable Specimens
5 unstained, positively charged slides collected in an IHC Specimen Transport Kit
Transport Temperature
Room temperature
Specimen Stability
Room temperature: Indefinite
Refrigerated: Indefinite
Frozen: Unacceptable
Refrigerated: Indefinite
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received frozen
Methodology
Immunohistochemistry
Setup Schedule
A.M.
Clinical Significance
The T-cell leukemia/lymphoma protein 1 (TCL1) is an AKT kinase regulator that is expressed in B cells up to the germinal stage and in plasmacytoid dendritic cells. TCL1 is strongly expressed, due to the chromosomal rearrangements, t(14;14)(q11;q32) and inv(14)(q11;q32), in 70% of cases of T-cell prolymphocytic leukemia (T-PLL) but is negative in all other mature T-cell lymphomas and leukemias. TCL1 is also expressed in nearly all cases of blastic plasmacytoid dendritic cell neoplasms, and can be used to distinguish this tumor from monocytic neoplasms. High TCL1 levels correlate with the pre-germinal center genetic subtype and are a strong adverse prognostic factor in B-cell chronic lymphocytic leukemia.